Through bioinformatics analysis and experimental assays, we learned that AQP9 expression levels were elevated in IBD and decreased in psoriasis, which offered new insights into the comorbidity mechanisms of IBD and psoriasis. Here, AQP9 is linked to inflammatory bowel disease.